RT @justinkeister5: Would love if more people would join me in supporting $NWBO and getting this vaccine to patients with little hope. htt…
@FuchsWriter @_K_Stiles @DrDavidACox And even more impressive combined with a checkpoint inhibitor:
@FuchsWriter @_K_Stiles @DrDavidACox One of my faves, teaching the immune system to fight deadly glioblastoma brain cancers: https://t.co/eog9Hi6AQJ
RT @justinkeister5: Would love if more people would join me in supporting $NWBO and getting this vaccine to patients with little hope. htt…
Totally agree Justin $NWBO
RT @justinkeister5: Would love if more people would join me in supporting $NWBO and getting this vaccine to patients with little hope. htt…
RT @justinkeister5: Would love if more people would join me in supporting $NWBO and getting this vaccine to patients with little hope. htt…
RT @justinkeister5: Would love if more people would join me in supporting $NWBO and getting this vaccine to patients with little hope. htt…
RT @justinkeister5: Would love if more people would join me in supporting $NWBO and getting this vaccine to patients with little hope. htt…
RT @justinkeister5: Would love if more people would join me in supporting $NWBO and getting this vaccine to patients with little hope. htt…
RT @justinkeister5: Would love if more people would join me in supporting $NWBO and getting this vaccine to patients with little hope. htt…
RT @justinkeister5: Would love if more people would join me in supporting $NWBO and getting this vaccine to patients with little hope. htt…
RT @justinkeister5: Would love if more people would join me in supporting $NWBO and getting this vaccine to patients with little hope. htt…
RT @justinkeister5: Would love if more people would join me in supporting $NWBO and getting this vaccine to patients with little hope. htt…
RT @justinkeister5: Would love if more people would join me in supporting $NWBO and getting this vaccine to patients with little hope. htt…
RT @justinkeister5: Would love if more people would join me in supporting $NWBO and getting this vaccine to patients with little hope. htt…
RT @justinkeister5: Would love if more people would join me in supporting $NWBO and getting this vaccine to patients with little hope. htt…
RT @justinkeister5: Would love if more people would join me in supporting $NWBO and getting this vaccine to patients with little hope. htt…
RT @justinkeister5: Would love if more people would join me in supporting $NWBO and getting this vaccine to patients with little hope. htt…
Would love if more people would join me in supporting $NWBO and getting this vaccine to patients with little hope. https://t.co/yU1qUHbONK
RT @alphavestcap: https://t.co/BYogOUXX8T @alphavestcap @rago_carlo 0 plus 1 = 6 . And , yes, a USPTO combo patent appears possible. $nw…
https://t.co/BYogOUXX8T @alphavestcap @rago_carlo 0 plus 1 = 6 . And , yes, a USPTO combo patent appears possible. $nwbo https://t.co/rBBETdNRL2 https://t.co/XaVqHK2Ret
RT @rago_carlo: These cancer vaccine results are breathtaking! rGBM 2yr survival ~10%, Physician's Choice, i.e. "SOC" ~20%, DCVax-L + "SOC…
RT @rago_carlo: @LynAldenContact Here’s the Phase 3 results published in JAMA Oncology for Murcidencel (DCVax-L) in newly diagnosed and rec…
RT @rago_carlo: @LynAldenContact Here’s the Phase 3 results published in JAMA Oncology for Murcidencel (DCVax-L) in newly diagnosed and rec…
RT @rago_carlo: @LynAldenContact Summarized below
RT @rago_carlo: @LynAldenContact Here’s the Phase 3 results published in JAMA Oncology for Murcidencel (DCVax-L) in newly diagnosed and rec…
@LynAldenContact Summarized below
@LynAldenContact Here’s the Phase 3 results published in JAMA Oncology for Murcidencel (DCVax-L) in newly diagnosed and recurrent GBM. $NWBO https://t.co/UdPMz7WsdO
RT @HassanClan: There is some criticism of #DCVax and the #JAMAOncology article: https://t.co/Ev4Fux9VpY Some arguments seem to repeat @st…
RT @rago_carlo: @elonmusk note the gibberish in this thread from the hedge fund guy that likes to short biotech companies. Could use some h…
RT @rago_carlo: @elonmusk note the gibberish in this thread from the hedge fund guy that likes to short biotech companies. Could use some h…
RT @rago_carlo: These cancer vaccine results are breathtaking! rGBM 2yr survival ~10%, Physician's Choice, i.e. "SOC" ~20%, DCVax-L + "SOC…
RT @rago_carlo: @elonmusk note the gibberish in this thread from the hedge fund guy that likes to short biotech companies. Could use some h…
RT @rago_carlo: @elonmusk note the gibberish in this thread from the hedge fund guy that likes to short biotech companies. Could use some h…
@elonmusk note the gibberish in this thread from the hedge fund guy that likes to short biotech companies. Could use some help here. Huge story. https://t.co/UdPMz7WsdO
@gliomadoc Combo trials? See below & NIC Spore funding of Dr Liau @UCLA, based, per Liau "on the strength of the science." Optune, however, has been dismissed by Liau who has said "(Most Clinicians) don't believe it works." Optune appears to be way dow
RT @HenryMuney: @ATLnsider @GoodPoint123 @technology #DCVax-L also has an excellent safety profile (left screenshot), starting with the mos…
$NWBO
RT @HenryMuney: @ATLnsider @GoodPoint123 @technology #DCVax-L also has an excellent safety profile (left screenshot), starting with the mos…
@MartinvdenBent These 70 Neuro Oncologists think that you are a fucking idiot https://t.co/115vXq4kU7
RT @HenryMuney: @ATLnsider @GoodPoint123 @technology #DCVax-L also has an excellent safety profile (left screenshot), starting with the mos…
RT @HenryMuney: @ATLnsider @GoodPoint123 @technology #DCVax-L also has an excellent safety profile (left screenshot), starting with the mos…
RT @HenryMuney: @ATLnsider @GoodPoint123 @technology #DCVax-L also has an excellent safety profile (left screenshot), starting with the mos…
@ATLnsider @GoodPoint123 @technology #DCVax-L also has an excellent safety profile (left screenshot), starting with the most difficult to treat cancer #GBM. $NWBO https://t.co/pfRDJT4azX There might be safety concerns with mRNA vaccines for cancer (middl
RT @HassanClan: There is some criticism of #DCVax and the #JAMAOncology article: https://t.co/Ev4Fux9VpY Some arguments seem to repeat @st…
There is some criticism of #DCVax and the #JAMAOncology article: https://t.co/Ev4Fux9VpY Some arguments seem to repeat @statnews, and AF (he who shall not be tagged) and have been debunked, but what are you thoughts? I am unchanged: #Paradigmshift #So
RT @metacollectiveG: $NWBO #DCVax @JAMAOnc The Journal Article is really getting some traction. The metrics are really great, in the 99th p…
RT @metacollectiveG: $NWBO #DCVax @JAMAOnc The Journal Article is really getting some traction. The metrics are really great, in the 99th p…
RT @Ali_boy_180: . Great news sweeping through the medical community #DCVax-L #GBM #Glioblastoma #murcidencel #NWBO $NWBO https://t.co/g…
RT @metacollectiveG: $NWBO #DCVax @JAMAOnc The Journal Article is really getting some traction. The metrics are really great, in the 99th p…
RT @metacollectiveG: $NWBO #DCVax @JAMAOnc The Journal Article is really getting some traction. The metrics are really great, in the 99th p…
RT @metacollectiveG: $NWBO #DCVax @JAMAOnc The Journal Article is really getting some traction. The metrics are really great, in the 99th p…
RT @metacollectiveG: $NWBO #DCVax @JAMAOnc The Journal Article is really getting some traction. The metrics are really great, in the 99th p…
RT @metacollectiveG: $NWBO #DCVax @JAMAOnc The Journal Article is really getting some traction. The metrics are really great, in the 99th p…
RT @metacollectiveG: $NWBO #DCVax @JAMAOnc The Journal Article is really getting some traction. The metrics are really great, in the 99th p…
RT @TVsJoeCarroll: $NWBO
RT @alphavestcap: https://t.co/U5Em5d641D @nwbo @alphavestcap
RT @metacollectiveG: $NWBO #DCVax @JAMAOnc The Journal Article is really getting some traction. The metrics are really great, in the 99th p…
RT @metacollectiveG: $NWBO #DCVax @JAMAOnc The Journal Article is really getting some traction. The metrics are really great, in the 99th p…
$NWBO
RT @metacollectiveG: $NWBO #DCVax @JAMAOnc The Journal Article is really getting some traction. The metrics are really great, in the 99th p…
https://t.co/U5Em5d641D @nwbo @alphavestcap
RT @metacollectiveG: $NWBO #DCVax @JAMAOnc The Journal Article is really getting some traction. The metrics are really great, in the 99th p…
RT @metacollectiveG: $NWBO #DCVax @JAMAOnc The Journal Article is really getting some traction. The metrics are really great, in the 99th p…
RT @metacollectiveG: $NWBO #DCVax @JAMAOnc The Journal Article is really getting some traction. The metrics are really great, in the 99th p…
$NWBO #DCVax @JAMAOnc The Journal Article is really getting some traction. The metrics are really great, in the 99th percentile. https://t.co/MKLAb2X14Y https://t.co/AlPcjxkS3o
RT @matthwilliams: As some of you know, we have concerns about the recent @NWBIO DCVax trial in GBM We have now clarified these in our sub…
RT @Ali_boy_180: . Great news sweeping through the medical community #DCVax-L #GBM #Glioblastoma #murcidencel #NWBO $NWBO https://t.co/g…
RT @alphavestcap: @alphavestcap $nwbo https://t.co/WJZWCUWgFc The JAMA paper (11/17/22) and the UCLA -LL combo data (12/5/22) have jumpe…
@alphavestcap $nwbo https://t.co/WJZWCUWgFc The JAMA paper (11/17/22) and the UCLA -LL combo data (12/5/22) have jumped the backlog at Sawston . 1)https://t.co/ISRkdaYmmH (Dr.Liau 12/5/22 Musella webinar presentation) 2) https://t.co/bhUDKROm2Z (11
RT @rago_carlo: @JoeSquawk @KryptyPop @rickcav A 500% increase in survival in toughest to treat / deadliest cancer might compel some networ…
RT @rago_carlo: @AJButton2 @tunguz $NWBO doubled survival with DCVax in this recent Phase 3 and extended to a 500% increase in survival whe…
RT @rago_carlo: @AJButton2 @tunguz $NWBO doubled survival with DCVax in this recent Phase 3 and extended to a 500% increase in survival whe…
RT @rago_carlo: @AJButton2 @tunguz $NWBO doubled survival with DCVax in this recent Phase 3 and extended to a 500% increase in survival whe…
#cureforcancer #Glioblastoma Incredible results😳 Congrats $NWBO
RT @rago_carlo: @AJButton2 @tunguz $NWBO doubled survival with DCVax in this recent Phase 3 and extended to a 500% increase in survival whe…
RT @rago_carlo: @AJButton2 @tunguz $NWBO doubled survival with DCVax in this recent Phase 3 and extended to a 500% increase in survival whe…
RT @peter_brit: Meaningful increases in the long-term tails of the survival curves in both nGBM and rGBM were also observed. GROUNDBREAKIN…
RT @rago_carlo: @AJButton2 @tunguz $NWBO doubled survival with DCVax in this recent Phase 3 and extended to a 500% increase in survival whe…
RT @rago_carlo: @AJButton2 @tunguz $NWBO doubled survival with DCVax in this recent Phase 3 and extended to a 500% increase in survival whe…
RT @rago_carlo: @tunguz @AviSchiffmann $NWBO cancer vaccine, check it out! This recent Phase 3 win was further extended with additional of…
RT @rago_carlo: @AJButton2 @tunguz $NWBO doubled survival with DCVax in this recent Phase 3 and extended to a 500% increase in survival whe…
@JoeSquawk @eastvillagetwt @marc_hauptman @rago_carlo @KryptyPop @rickcav Omg… unbelievable lol, why not this instead? Results Featured In JAMA Oncology Peer Reviewed Publication: https://t.co/qM4mpPFvdZ
RT @RichFairgrieve: For those of you unfamiliar with UCLA that's a photo of Dr. Linda Liau the lead investigator of the successful P3 trial…